IRIS
BARRECA, Maria Letizia
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 8.026
EU - Europa 3.328
AS - Asia 1.675
SA - Sud America 502
Continente sconosciuto - Info sul continente non disponibili 52
AF - Africa 41
OC - Oceania 3
Totale 13.627
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.929
RU - Federazione Russa 1.689
SG - Singapore 672
CN - Cina 501
BR - Brasile 437
IE - Irlanda 374
SE - Svezia 329
UA - Ucraina 285
HK - Hong Kong 180
DE - Germania 173
VN - Vietnam 162
GB - Regno Unito 137
FI - Finlandia 82
FR - Francia 78
IT - Italia 75
CA - Canada 52
IN - India 41
AR - Argentina 28
MX - Messico 23
CZ - Repubblica Ceca 18
PL - Polonia 16
BD - Bangladesh 15
IQ - Iraq 15
TR - Turchia 15
BE - Belgio 14
NL - Olanda 12
EC - Ecuador 11
ZA - Sudafrica 11
PK - Pakistan 10
UZ - Uzbekistan 10
ES - Italia 9
TN - Tunisia 8
VE - Venezuela 8
IL - Israele 7
EG - Egitto 6
IR - Iran 6
JP - Giappone 6
CI - Costa d'Avorio 5
CO - Colombia 5
HN - Honduras 5
ID - Indonesia 5
MA - Marocco 5
UY - Uruguay 5
AE - Emirati Arabi Uniti 4
AT - Austria 4
CL - Cile 4
GT - Guatemala 4
LT - Lituania 4
PH - Filippine 4
A2 - ???statistics.table.value.countryCode.A2??? 3
AL - Albania 3
AZ - Azerbaigian 3
BG - Bulgaria 3
CH - Svizzera 3
GR - Grecia 3
KE - Kenya 3
PE - Perù 3
SV - El Salvador 3
CY - Cipro 2
EE - Estonia 2
JO - Giordania 2
KG - Kirghizistan 2
LV - Lettonia 2
MY - Malesia 2
NP - Nepal 2
NZ - Nuova Zelanda 2
PA - Panama 2
RO - Romania 2
RS - Serbia 2
SA - Arabia Saudita 2
TT - Trinidad e Tobago 2
VG - Isole Vergini Britanniche 2
AU - Australia 1
BA - Bosnia-Erzegovina 1
BO - Bolivia 1
BY - Bielorussia 1
CR - Costa Rica 1
CW - ???statistics.table.value.countryCode.CW??? 1
DK - Danimarca 1
ET - Etiopia 1
GA - Gabon 1
HU - Ungheria 1
IS - Islanda 1
JM - Giamaica 1
KH - Cambogia 1
KR - Corea 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
LK - Sri Lanka 1
MD - Moldavia 1
MK - Macedonia 1
NG - Nigeria 1
NI - Nicaragua 1
NO - Norvegia 1
PR - Porto Rico 1
SK - Slovacchia (Repubblica Slovacca) 1
TH - Thailandia 1
Totale 13.579
Salva come PNG Salva come JPEG
Città #
Dallas 4.548
Moscow 496
Jacksonville 488
Singapore 392
Ashburn 381
Dublin 374
Chandler 364
Nyköping 224
San Jose 187
Hong Kong 180
Beijing 175
Council Bluffs 173
Dong Ket 115
Los Angeles 94
The Dalles 77
Princeton 76
Cambridge 73
Medford 71
Lauterbourg 61
Des Moines 58
Boardman 50
Columbus 49
Dearborn 41
Buffalo 40
Lancaster 28
São Paulo 28
Ann Arbor 27
Santa Clara 27
Woodbridge 27
Tianjin 23
Chicago 20
New York 20
Guangzhou 19
Wilmington 19
Brno 18
Brooklyn 18
Nanjing 18
Jinan 16
Rio de Janeiro 16
Belo Horizonte 15
Haikou 15
Ho Chi Minh City 15
Brussels 14
London 14
Munich 14
Ottawa 14
Atlanta 13
Phoenix 13
Warsaw 13
Hebei 12
Hyderabad 12
Orem 12
Washington 12
Hanoi 11
Milan 11
Shenyang 11
Taizhou 11
Montreal 10
Saint Petersburg 10
Seattle 10
Amsterdam 9
Frankfurt am Main 9
Pune 9
San Francisco 9
San Mateo 9
Tashkent 9
Zhengzhou 9
Denver 8
Manchester 8
Brasília 7
Campinas 7
Curitiba 7
Hangzhou 7
Norwalk 7
Poplar 7
Santo André 7
Stockholm 7
Toronto 7
Auburn Hills 6
Baghdad 6
Istanbul 6
Johannesburg 6
Leawood 6
Mexico City 6
Tokyo 6
Tunis 6
Abidjan 5
Ardabil 5
Campo Grande 5
Dhaka 5
Fuzhou 5
Houston 5
Lahore 5
Newark 5
North Bergen 5
Pittsburgh 5
Redondo Beach 5
Riva 5
Shanghai 5
Shenzhen 5
Totale 9.633
Salva come PNG Salva come JPEG
Nome #
1,3-diidro-benzimidazoloni analoghi: progettazione, sintesi e SAR di nuovi inibitori non-nucleosidici dell'RT 4.625
1,3-THIAZOLIDIN-4-ONES:POTENT AND HIGHLY SELECTIVE ANTI-HIV-1 AGENTS 291
5-Arylidene-2-imino-4-thiazolidinones: Design and synthesis of novel anti-inflammatory agents 265
Molecular dynamics studies of the wild-type and double mutant HIV-1 integrase complexed with the 5CITEP inhibitor: Mechanism for inhibition and drug resistance 193
Anti-HIV agents: design and discovery of new potent RT inhibitors 185
Comparative molecular field analysis (CoMFA) and docking studies of non-nucleoside HIV-1 RT inhibitors (NNIs) 179
Binding mode prediction of Strand Transfer HIV-1 Integrase Inhibitors using Tn5 transposase as a plausible surrogate model for HIV-1 Integrase 176
Analysis of the full-length integrase-DNA complex by a modified approach for DNA docking 167
Binding modes of noncompetitive AMPA antagonists: a computational approach 166
A comprehensive structural overview of p38α MAPK in complex with type I inhibitors 164
Computational strategies in discovering novel non-nucleoside inhibitors of HIV-1 RT 162
Design, synthesis, structure-activity relationships, and molecular modeling studies of 2,3-diaryl-1,3-thiazolidin-4-ones as potent anti-HIV agents 160
3-D QSAR MODELS AND DOCKING STUDIES OF REVERSIBLE INHIBITORS OF TYPE A AND B MONOAMINE OXIDASE 155
Anticonvulsant activity of tetrahydroisoquinoline derivatives as potential new AMPA receptor antagonists 153
Design and synthesis of 2,3-diaryl-1,3-thiazolidin-4one potent HIV-1 RT-inhibitors. 153
Discovery of 2,3-diaryl-1,3-thiazolidin-4-ones as potent anti- HIV-1 agents 150
Computational and synthetic approaches for the discovery of HIV-1 integrase inhibitors 144
Computational studies of inhibitor resistance in HIV-1 integrase 144
A refined pharmacophore model for HIV-1 integrase inhibitors: Optimization of potency in the 1H-benzylindole series 143
COMPUTATIONAL APPROACHES IN DISCOVERING NOVEL ANTI-AIDS AGENTS 143
Efficient 3D Database screening for novel HIV-1 IN inhibitors 142
Pharmacophore-Based Design of HIV-1 Integrase Strand-Transfer Inhibitors 136
Antagonisti non-competitivi del recettore AMPA: progettazione, sintesi, SAR e studio del profilo farmacocinetico 136
Computational and synthetic approaches for the discovery of HIV-1 integrase inhibitors 135
Synthesis of new potential HIV-1 integrase inhibitors 133
Structure-activity hypothesis in the design of new AMPA receptor antagonists. 124
Progettazione Sintesi e SAR di nuovi derivati tetraidroisochinolinici. 124
Progettazione razionale e "green" sintesi di nuovi inibitori dell'integrasi dell'HIV-1 119
Computational Strategies for Discovering novel HIV-1 RT Inhibitors 117
Design and Synthesis of NR2B Subtype-Selective Antagonist 116
Design and synthesis of new HIV-1 NNRTIs 115
Dynamic pharmacophore model development and testing 113
MD STUDIES OF THE WILD TYPE AND MUTANT HIV-1 INTEGRASE COMPLEXED WITH THE 5CITEP INHIBITOR: MECHANISM FOR INHIBITION AND DRUG RESISTANCE 113
Sviluppo del modello DNA-integrasi dell'HIV-1: studi di docking e di dinamica molecolare 112
Molecular modeling e disign di inibitori dell'integrasi dell'HIV-1 112
DISCOVERY OF HIV-1 INTEGRASE INHIBITORS BY MOLECULAR MODELING STUDIES 109
New trends in the development of AMPA receptor antagonists 109
Synthesis and anticonvulsant properties of 1,2,3,4-tetrahydroisoquinolin-1-ones 108
QSAR study of anticonvulsant negative allosteric modulators of the AMPA receptor 108
Drug design and synthetic approach for the discovery of novel HIV-1 integrase inhibitors 107
Homology Modelling of AMPA Receptors: Route to the Identification of Noncompetitive Antagonists Binding Site 107
Tetrahydroisoquinoline derivatives: a new class of non-competitive AMPA receptor antagonists with potential anticonvulsant activity 107
Preclinical evaluation of 1H-benzylindole derivatives as novel human immunodeficiency virus integrase strand transfer inhibitors 107
Search for noncompetitive 2-amino-3(3-hydroxy-5-methyl-4-isoxazolyl)propionic acid receptor (AMPAR) antagonists: Synthesis, pharmacological properties, and computational studies 106
DISCOVERY OF 2,3-DIARYL-1,3-THIAZOLIDIN-4-ONES AS POTENT HIV-1 NNRTIS BY MOLECULAR MODELING STUDIES 105
Search fo non-competitive AMPA antagonists: Synthesis, pharmacological properties and computational studies 105
Molecular dynamics studies of the full-length integrase-DNA complex 103
HIV-1 Integrase Inhibitors: Pharmacophore Modeling and Rational Drug Design 102
Discovery of novel HIV-1 integrase inhibitors through computational strategies 101
PROPOSED MECHANISM FOR THE HIV-1 IN INHIBITION AND DRUG RESISTANCE BY MOLECULAR DYNAMICS STUDIES 100
Noncompetitive AMPA receptor antagonists: Synthetic approaches, molecular modeling and pharmacological profile 97
Noncompetitive AMPA receptor antagonists and proposed pharmacophore model 97
Molecular dynamics studies of the HIV-1 integrase 95
Pharmacophore modeling as an efficient tool in the discovery of novel noncompetitive AMPA receptor antagonists 95
Tetrahydroisoquinolin-1-ones as anticonvulsant agents 94
Discovery of a novel and highly potent noncompetitive AMPA receptor antagonist 93
Design e sintesi di nuovi antagonisti noncompetitivi del recettore AMPA 92
Design e sintesi di nuovi inibitori dell'integrasi dell'HIV-1 92
DYNAMIC PHARMACOPHORE MODEL DEVELOPMENT AND TESTING 91
Tetrahydroisoquinoline a new class of noncompetitive AMPA receptor antagonists as potential anticonvulsant agents 91
NNRTI TBZ-ANALOGHI: PROGETTAZIONE RAZIONALE, SINTESI E SAR 91
Novel N1-substituted 1,3-dihydro-2H-benzimidazol-2-ones as potent non-nucleoside riverse transcriptase inhibitors 90
Pharmacophore-based design of HIV-1 integrase inhibitors 90
Isoquinoline derivatives as noncompetitive AMPA receptor antagonists 90
Docking studies on a new human immunodeficiency virus integrase-Mg-DNA complex: phenyl ring exploration and synthesis of 1H-benzylindole derivatives through fluorine substitutions 89
Discovery of a new class of AMPA receptor antagonists containing a tetrahydroisoquinoline skeleton, 89
Rational design, synthesis and SAR of HIV-1 integrase Inhibitors 87
Structure-based pharmacophore identification of new chemical scaffolds as non-nucleoside reverse transcriptase inhibitors 85
Rational design and synthesis of novel NNRTI TBZ analogues 85
Human immunodeficiency virus integrase inhibitors efficiently suppress feline immunodeficiency virus replication in vitro and provide a rationale to redesign antiretroviral treatment for feline AIDS 83
Progettazione di nuovi agenti anti-HIV e individuazione di nuovi lead compound 80
Identification of Anti-Influenza A Compounds Inhibiting the Viral Non-Structural Protein 1 (NS1) Using a Type I Interferon-Driven Screening Strategy 66
Pharmacophore-Based Design of HIV-1 Integrase Strand-Transfer Inhibitors 66
Induced-Fit Docking Approach Provides Insight into the Binding Mode and Mechanism of Action of HIV-1 Integrase Inhibitors 42
Structure-based pharmacophore identification of new chemical scaffolds as non-nucleoside reverse transcriptase inhibitors 37
null 28
null 27
null 27
null 25
null 25
null 24
Prion protein ligands as therapeutic agents for neurodegenerative disorders 15
Totale 13.627
Salva come PNG Salva come JPEG
Categoria #
all - tutte 36.128
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 36.128
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022320 0 0 0 0 35 0 42 13 8 1 62 159
2022/20231.321 94 90 65 108 108 157 30 99 493 5 65 7
2023/2024339 26 53 17 46 34 68 8 26 1 29 8 23
2024/20251.226 20 35 49 101 14 44 16 289 321 52 84 201
2025/20267.880 131 1.471 3.216 304 269 917 500 417 440 120 66 29
2026/2027727 71 263 144 239 10 0 0 0 0 0 0 0
Totale 13.627